The race for a vaccine for Covid-19 has begun, with the US and China in the lead with clinical trials and testing. Oxford University visiting researcher Hayson Wang points out that countries will have to work together in order to develop an effective vaccine, rather than compete against one another.
Convinced that China has been stealing information and know-how through people insurgents at all levels, the US is making haste to withdraw opportunities for Chinese to tap on US innovation in any way. Thus far, experts of Chinese descent who work in particularly sensitive fields in the US are facing the brunt of increased scrutiny. Does this signal the end of long-held American generosity and openness in sharing knowledge, at least as it applies to the Chinese?
Associate professor Kenneth Huang from the NUS Business School observes that by 2012, China had overtaken the US in terms of the number of patents filed domestically. But this does not mean that all the innovations filed were truly novel or valuable. His recent study on Chinese state-owned enterprises shows that self-serving human factors are at play.